Park Medi World Limited’s shares rose following the launch of a liver transplant programme at Signature Hospital, aimed at enhancing transplant services for patients in Delhi-NCR. Despite initial gains, stock traded 0.75% lower at ₹276.3 on BSE during the day.
Read more at the source
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and credits belong to the original authors and publishers.